Skip to content

Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease

Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease (riskINN )

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05472207
Acronym
riskINN
Enrollment
5000
Registered
2022-07-25
Start date
2021-01-01
Completion date
2030-01-31
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Healthy

Brief summary

The aim of this study is to develop risk prediction models for the early detection of high-risk patients with structural, rhythmological or inflammatory cardiovascular diseases.

Interventions

None listed

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Decision-eligible male and female patients ≥18 years of age * Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease * Informed consent for participation in the clinical trial

Exclusion criteria

* missing infromed consent * pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frame
combination of cardiovascular mortality, stroke, myocardial infarction and hospitalization due to decompensated heart failurefrom inclusion to end of study (max. 4 years)

Secondary

MeasureTime frame
cardiovascular mortalityfrom inclusion to end of study (max. 4 years)
strokefrom inclusion to end of study (max. 4 years)
myocardial infarctionfrom inclusion to end of study (max. 4 years)
total mortalityfrom inclusion to end of study (max. 4 years)
hospitalization due to cardiovascular conditionfrom inclusion to end of study (max. 4 years)
admission to intensive care unitfrom inclusion to end of study (max. 4 years)
severe arrythmic eventsfrom inclusion to end of study (max. 4 years)
hospitalization due to decompensated heart failurefrom inclusion to end of study (max. 4 years)

Countries

Austria

Contacts

Primary ContactAxel Bauer, Univ.-Prof. Dr.
axel.bauer@i-med.ac.at+43 512 504 25621

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026